Literature DB >> 21357069

Preparation of GST Fusion Proteins.

Margret B Einarson, Elena N Pugacheva, Jason R Orlinick.   

Abstract

INTRODUCTIONThis protocol describes the preparation of glutathione-S-transferase (GST) fusion proteins, which have had a wide range of applications since their introduction as tools for synthesis of recombinant proteins in bacteria. GST was originally selected as a fusion moiety because of several desirable properties. First and foremost, when expressed in bacteria alone, or as a fusion, GST is not sequestered in inclusion bodies (in contrast to previous fusion protein systems). Second, GST can be affinity-purified without denaturation because it binds to immobilized glutathione, which provides the basis for simple purification. Consequently, GST fusion proteins are routinely used for antibody generation and purification, protein-protein interaction studies, and biochemical analysis.

Entities:  

Year:  2007        PMID: 21357069     DOI: 10.1101/pdb.prot4738

Source DB:  PubMed          Journal:  CSH Protoc        ISSN: 1559-6095


  3 in total

1.  In vitro sumoylation of recombinant proteins and subsequent purification for use in enzymatic assays.

Authors:  Vasupradha Vethantham; James L Manley
Journal:  Cold Spring Harb Protoc       Date:  2009-01

2.  Inhibition of protein phosphatase 2A (PP2A) prevents Mcl-1 protein dephosphorylation at the Thr-163/Ser-159 phosphodegron, dramatically reducing expression in Mcl-1-amplified lymphoma cells.

Authors:  Shanna K Nifoussi; Nora R Ratcliffe; Deborah L Ornstein; Gary Kasof; Stefan Strack; Ruth W Craig
Journal:  J Biol Chem       Date:  2014-06-17       Impact factor: 5.157

3.  Identification of the novel activity-driven interaction between synaptotagmin 1 and presenilin 1 links calcium, synapse, and amyloid beta.

Authors:  Akira Kuzuya; Katarzyna M Zoltowska; Kathryn L Post; Muriel Arimon; Xuejing Li; Sarah Svirsky; Masato Maesako; Alona Muzikansky; Vivek Gautam; Dora Kovacs; Bradley T Hyman; Oksana Berezovska
Journal:  BMC Biol       Date:  2016-03-31       Impact factor: 7.431

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.